Digest Network Come funziona
Network
/
Società
Tr
Non verificato

Travere Therapeutics, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieSaluteScienza

62 comunicati stampa

Guarda tutti i comunicati
23/10/2026
Salute
Sanità
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Eventi
Industria
Travere Presents New Biomarker Data at ASN Kidney Week Suggesting FILSPARI® (sparsentan) May Modify Underlying Disease Pathophysiology in IgA Nephropathy
Fonte
Travere Therapeutics, Inc.
Emittente
Business Wire
1.00
0
12/10/2026
Biotecnologia
Farmaceutica
Salute
Mercato azionario
Finanza
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fonte
Travere Therapeutics, Inc.
Emittente
Business Wire
1.00
0
02/10/2026
Fiere
Eventi
Industria
Salute
Sanità
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Travere to Present New Data Supporting FILSPARI® (sparsentan) as Foundational Treatment in IgA Nephropathy and FSGS at ASN Kidney Week 2026
Fonte
Travere Therapeutics, Inc.
Emittente
Business Wire
1.00
0
23/09/2026
Industria
Biotecnologia
Igiene alimentare
Salute
Farmaceutica
Medicina - Varie
Travere Therapeutics Receives Notice of Allowance from the U.S. Patent and Trademark Office for U.S. Patent Application Directed to Certain Methods of Using FILSPARI® (sparsentan) in Focal Segmental Glomerulosclerosis
Fonte
Travere Therapeutics, Inc.
Emittente
Business Wire
1.00
0
21/09/2026
Mercato del lavoro
Salute
Biotecnologia
Sanità
Scienza
Farmaceutica
Travere Therapeutics Announces Planned Chief Executive Officer Transition
Fonte
Travere Therapeutics, Inc.
Emittente
Business Wire
1.00
0
17/09/2026
Salute
Sanità
Scienza
Farmaceutica
Biotecnologia
Eventi
Travere Therapeutics to Present at the Stifel 2026 Virtual Immunology and Inflammation Forum
Fonte
Travere Therapeutics, Inc.
Emittente
Business Wire
1.00
0
11/09/2026
Mercato azionario
Finanza
Biotecnologia
Farmaceutica
Salute
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fonte
Travere Therapeutics, Inc.
Emittente
Business Wire
1.00
0
12/08/2026
Mercato del lavoro
Finanza
Mercato azionario
Salute
Scienza
Sanità
Farmaceutica
Biotecnologia
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fonte
Travere Therapeutics, Inc.
Emittente
Business Wire
1.00
0
05/08/2026
Eventi
Web e Social Network
Salute
Biotecnologia
Medicina - Varie
Scienza
Farmaceutica
Travere Therapeutics to Participate at Upcoming Investor Conferences
Fonte
Travere Therapeutics, Inc.
Emittente
Business Wire
1.00
0
04/08/2026
Web e Social Network
Telefonia e Varie
Mercato azionario
Biotecnologia
Farmaceutica
Salute
Travere Therapeutics Reports Second Quarter 2026 Financial Results
Fonte
Travere Therapeutics, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0